The global nuclear medicine radioisotopes market is expected to grow at a CAGR of around 8.4% during 2024-2033. This report on global nuclear medicine radioisotopes market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global nuclear medicine radioisotopes market by segmenting the market based on product, application, end user, and region. Also, detailed profiles of companies operating in the nuclear medicine radioisotopes market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers
• Rising Burden of Cancer and Cardiac Disorders
• Widening Applications of Nuclear Medicine

Market Challenges
• Reimbursement Complications
• Regulatory Issues

Historical & Forecast Period

Base Year: 2023
Historical Period: 2019-2023
Forecast Period: 2024-2033

Market by Product
• Diagnostics
   - Technetium-99m (Tc-99m)
   - Gallium-67
   - Thallium-201
   - Fluorine-18
   - Others
• Therapeutics
   - Rhenium-186
   - Iodine-131
   - Samarium-153
   - Yttrium-90
   - Others

Market by Application
• Cardiology
• Oncology
• Thyroid
• Neurology
• Others

Market by End User
• Hospitals
• Diagnostic Centers
• Specialty Clinics
• Education and Research Institutes
• Others

Market by Region
• Europe
   - Germany
   - United Kingdom
   - France
   - Italy
   - Spain
   - Russia
   - Netherlands
   - Rest of Europe
• North America
   - United States
   - Canada
• Asia Pacific
   - China
   - Japan
   - India
   - South Korea
   - Australia
   - Indonesia
   - Rest of Asia Pacific
• Latin America
   - Mexico
   - Brazil
   - Argentina
   - Rest of Latin America
• Middle East & Africa
   - Saudi Arabia
   - Turkey
   - Iran
   - United Arab Emirates
   - Rest of Middle East & Africa